jRCT2021230019
Untitled Trial
Phase II clinical study of OP 2024 in advanced Parkinson's disease
OHARA Pharmaceutical Co., Ltd.·Japan Registry Clinical TrialRecruiting
Study focus
- Disease/Condition
- Parkinson's disease
- Study type
- Interventional
Sponsor & location
- Primary sponsor
- OHARA Pharmaceutical Co., Ltd.
Timeline & enrollment
- Phase
- N/A
- Start date
- N/A
- End date
- N/A
ICD-10 classifications
Parkinson diseaseParkinsonism in diseases classified elsewhereDementia in Parkinson diseaseSecondary parkinsonismPostencephalitic parkinsonism
Data source
- Registry
- Japan Registry Clinical Trial
- Trial ID
- jRCT2021230019
- Type
- Non-Device Trial
About this record
Access comprehensive clinical trial information for jRCT2021230019 through Pure Global AI's free database. This phase not specified trial is sponsored by OHARA Pharmaceutical Co., Ltd. and is currently Recruiting. The study focuses on Parkinson's disease.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to Japan Registry Clinical Trial data, helping medical device and pharmaceutical companies navigate clinical research efficiently.